London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Nice of Tom to have plaguerised my recent post and used it for his trading update!
.
40p with warrants and Tom will pop up, bobbing of the head, shrug of the shoulders, this is what dealing with the NHS is like unfortunately, long lead in times, sure we will get there, bear with us, salaries to pay, light switches to be left on overnight, holidays to be paid for.
5500 shares sold early. Not exactly a ringing endorsement Tom! Betting the farm on the NHS might not work....
Depressing, yet not entirely unexpected. Someone at the nhs is leading Tom a very merry dance, what now for QVH extend the pilot until 2025? It’s hard to justify the employment of a NHS partnerships specialist, what are they doing? we don’t have any NHS partners to specialise with!
Where's India? That was my other thought.
I know its only charitable contributions at this stage, tied in with big pharmas charitable arm - so where is the update, the progress, the headlines to woo the Indian Govt of Modi to fund the billions that the programme to eradicate TB utilising Bleepa?
The Company has raised approximately £11.2 million in aggregate (before expenses)
Income of £1.2m Only raised it by 15% this year.
They haven't paid out for India yet, that's why there is £4.3m left as of April ...
"Using part of the proceeds of the Fundraising, the Company is planning to undertake a pilot scheme of the tuberculosis screening solution within some initial sites in India. The Director's believe that there is potential to generate significant revenues per year from each state that the solution is rolled out in.
Once they had it spelt out it was charitable contributions only they've held fire on rolling it out after realising it was a sound bite from Modi to 'eradicate TB in India by 2025'
That's why there's no news on India in the update!
Cash left £4.3m as at April, another two months of cash burn to go yet, NHS not paying out of current budgets.
Will Labour let them use Whattsapp?
' the Board now believes that these larger NHS opportunities are likely to mature during the upcoming financial year.'
Tom needs to resign, Salesman put in his place.
Cash and cash equivalents as at 30 November 2023 were £5.37m (30 November 2022: £9.23m)
Remember they always place long before they actually run out of cash in case the first placing cant be got away into the market so they pump it up with news and interviews, as soon as his little quiff pops up on on the usual channels you know its being worked.
Quick game of Hangman
P - A C - NG
I wonder what Unicorn are thinking?
As part of the Placing, Unicorn VC, a substantial shareholder of the Company and therefore a Related Party as defined by the AIM Rules ("Related Party"), has subscribed for a total of 285,714,290 Placing Shares at the Issue Price under the Placing. Following completion of the Fundraising, Unicorn VC will have an aggregate interest in 485,714,290 Ordinary Shares, representing 18.2 per cent. of the enlarged share capital* of the Company.
It's just another crap AIM company to add to the long list. 💩
It's the endless hope and hype here that makes it fun
double your money, sell and play again
sometime, that might change
but for now it's a new game of spot the time to buy.....and that might be someway off
General election and early trading update announced on the same day with the expectation of contracts with the NHS to be in place in the coming financial year, coincidence??? or a warning of a fund raise coming?
The extract below is from an RNS issued today our old friends IQAI. Tom had better get a move on as this product already does a lot of Bleepa functions and is now working on adding imaging.
On the trading update the further pushing out of contracts imperils our cash position ,and there is no positive statement in the update on the length of the runway . I fear further dilution. And do any of us know what the cash position is now-what is the market expectation for cash we are in line with. Too vague .... So once again Tom had raised high expectations of hearing news in the short tem and now again has to row back. Either he is naive or not telling the whole truth . Very disappointed . The QVS procurement is particularly galling given last year's debacle.
The full IQAI rns is worth a read -they are catching us up.
"The product roadmap for IB Nimble is clear. By the end of 2024, our development team will have completed significant enhancements to the software architecture, including the addition of a highly requested feature - viewing medical images," said Tim Dondlinger, COO of IB. "In advance of that, we are already working on our sales pipeline," added Mr. Dondlinger.